BioDlink International Company Limited (HKG:1875)
Hong Kong · Delayed Price · Currency is HKD 5.71
+0.46 (8.76%)
At close: Mar 27, 2026
HKG:1875 Revenue
In the year 2025, BioDlink International Company had annual revenue of 747.65M CNY, down -31.93%. BioDlink International Company had revenue of 258.51M in the half year ending December 31, 2025, a decrease of -42.88%.
Revenue
747.65M CNY
Revenue Growth
-31.93%
P/S Ratio
5.30
Revenue / Employee
1.24M CNY
Employees
604
Market Cap
4.41B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 747.65M | -350.68M | -31.93% |
| Dec 31, 2024 | 1.10B | 317.70M | 40.70% |
| Dec 31, 2023 | 780.63M | 338.45M | 76.54% |
| Dec 31, 2022 | 442.18M | 365.85M | 479.34% |
| Dec 31, 2021 | 76.33M | 53.83M | 239.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viva Biotech Holdings | 2.01B |
| AIM Vaccine | 1.38B |
| Shandong Boan Biotechnology | 829.27M |
| Medtide | 546.29M |
| Qyuns Therapeutics | 351.04M |
| Mirxes Holding Company | 166.32M |
| Antengene Corporation | 117.22M |
| Jacobio Pharmaceuticals Group | 59.56M |